{"date":"2026-05-02","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6598-2026-05-02-2145-10men2t","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-05-02","time":"21:45:43","subject":"代子公司Applied BioCode,Inc.公告所開發的20項呼吸道多元分子檢測套組(RPP)及自動化診斷系統(MDx3000)，搭配賽默飛世爾萃取儀器前處理系統，取得美國FDA上市許可。","clause":"第10款","fact_date":"2026-05-02","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-05-02 21:45，「代子公司Applied BioCode,Inc.公告所開發的20項呼吸道多元分子檢測套組(RPP)及自動化診斷系統(MD」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}